Health Canada Investigating Blood Clot Reports After U.S. Pauses J&J Vaccine

Health Canada Investigating Blood Clot Reports After U.S. Pauses J&J Vaccine
A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, Calif., on March 25, 2021. Lucy Nicholson/Reuters
|Updated:

OTTAWA—Health Canada says it is investigating reports a second vaccine may be linked to extremely rare cases of blood clots.

The United States Centers for Disease Control and Prevention and the Food and Drug Administration issued a joint statement Tuesday recommending a “pause'' in using the single-dose Johnson & Johnson vaccine after six women developed blood clots after being vaccinated.